letterhead
Patient News 

 

Annual Patient Workshop

 

Save the date:

Sunday

 February 17, 2013

 

Hilton Dallas-Fort Worth Lakes Executive Conference Center 

 

 

Therapy Tip

 

As with all treatments, practitioners will weigh the risks versus benefits of inflammation therapy. After considering the science, the pharmacology and their patient's clinical picture, it should be evident that IT is as safe as, or safer than, conventional treatments. The numerous anecdotal reports of recovery suggest that, for many patients, IT is the best treatment option.

 

Recovery Reports

 

We are contacted daily by people with chronic illnesses who are looking for an effective treatment. Many ask us to provide evidence of efficacy in the form of statistics or stories. If you have recovered your health or had significant symptom improvement with Inflammation Therapy (or a similar treatment), please help us 'pay it forward' by telling your story. We will post it in the public section of our website to encourage others. Any report, short or long, with or without objective data (e.g., lab results, imaging reports) would be helpful. Please

send your story to

our email .

Thank you!  

To see the latest recovery reports,

click here. 

 

CIR Library Access

 

Access to our free, extensive, easy-to-read Library of Information

 (see this sample page)

and Physicians' Reference Library is available to anyone, without enrollment in our counseling program. If you're interested in using this resource, please send a request to our email

 address along with your doctor's name and fax number (in the US or Canada) or his/her email address, so we can notify your doctor that you have access to this information.

A list of the articles in our libraries is available at this link.

 Physicians may use CIR libraries even if they don't have a patient enrolled in our counseling program. Interested medical practitioners should contact CIR and ask to register.

 

Survey

 

Volunteers who have a diagnosis of autoimmune or inflammatory disease or are chronically ill but who are not being treated with Inflammation Therapy, the Marshall Protocol or the Stillpoint Protocol are needed to be in the control group of our clinical study. If you meet these criteria and would like to take part in this project (which will only take a few minutes

each month), please 

contact us at our  

email address.

 

  "Thanks for the effort to track (data via survey),

it will be the underpinnings of this treatment at some time." ~James Graves

 

 CIR is an IRS-recognized 501(c)3 non-profit charitable organization. 

Donate to CIR

 in support of our educational and research efforts. 

shaking hands

 
Contact Us
you may phone us toll free from anywhere in the US and Canada
1-888-846-2474
Skype
Chronic.Illness.Recovery

Like us on Facebook
 

 

Have you enjoyed this newsletter?

  

 

We are happy to report that our website has been extended with HONcode another year. The HONcode certification is an ethical standard aimed at offering quality health information. 

 

Issue: 31
May 2012 
newsletter_banner

 

Greetings!

 

May marks the end of a school year for many and a break in the educational process. At CIR we continue our year-round focus on reaching out to medical practitioners interested in learning about Inflammation Therapy (IT). Patients are asking their doctors to authorize their enrollment in CIR's counseling program in order to facilitate their understanding of this treatment. Their weekly reports and the Nurse responses are faxed to their physicians to inform them about managing IT and to ensure they agree with the advice given.

 

Thanks to everyone who has informed their physician about CIR. We expect our efforts will result in a lower therapy failure rate and increase the likelihood that this effective treatment will be offered to more patients.

 

Don't forget to mark your calendar for the next Patient Workshop to be held in the Dallas area Sunday, February 17, 2013. We'd love to meet you! 

 

signature            Belinda 

.
 
About Inflammation Therapy 

 

Vitamin D metabolites

 

Although vitamin D is commonly called a vitamin, it is not an essential dietary vitamin because it can be synthesized in adequate amounts by all mammals from sunlight. Vitamin D was misnamed when it was discovered in 1922.

 

Vitamin D has several metabolites but the most common use of the term refers to the major circulating form, the pro-hormone 25-D.

 

25-D is also known as calciferol, calcidiol, 25-hydroxycholecalciferol or 25-hydroxyvitamin-D. Several forms of 25-D exist (D1, D2, D3, D4, D5). The two major forms are vitamin D2 or ergocalciferol, and vitamin D3 or cholecalciferol. 25-D without a subscript refers to either D2 or D3 or both. These are known collectively as calciferol.

 

Calciferol (25-D) is converted to calcidiol (25-D) in the liver. Calcidiol is, primarily, used in the production of 1,25-D (the active D-metabolite).

25-D is usually the only D-metabolite measured (using ng/ml) to determine if a patient is deficient in vitamin D. Two forms of 25-D (D3 and D2) are often tested.

 

Measures of D3 (cholecalciferol) serum levels reflect endogenous synthesis from exposure to sunlight as well as intake from the diet (naturally from animal products) and artificially from supplementation.

 

Measures of D2 (ergocalciferol) serum levels reflect the presence of the form of 25-D which is produced by some organisms of phytoplankton, invertebrates, yeasts, and higher fungi such as mushrooms.

 

25-D is unique because it functions as a pro-hormone and because the body can synthesize it (as vitamin D3) when sun exposure is adequate (hence its nickname, the "sunshine vitamin"). 

 

1,25-D (the active metabolite)

 

25-D (calcidiol) is converted by the kidneys (and other tissues) to 1,25-D, the biologically-active vitamin D metabolite.

 

1,25-D is also known as calcitriol or 1,25-dihydroxycholecalciferol or 1,25-dihydroxyvitamin-D3. 1,25-D (a potent paracrine mediator) circulates as a secosteroid hormone in the blood (a hormone is a chemical substance produced by one organ and then transported in the bloodstream to a target organ, where it causes a specific biological action) and affects almost all cellular activity.

 

When discussing vitamin D, it's important to differentiate the pro-hormone form (25-D) from the active hormone form (1,25-D).

 

light

 

From the CIR Scientific Reference Library

  

Vitamin D: Metabolism


 
"The biologically active metabolite of vitamin D, 1,25(OH)2D3, affects mineral homeostasis and has numerous other diverse physiological functions including effects on growth of cancer cells and protection against certain immune disorders. This chapter reviews the role of vitamin D hydroxylases in providing a tightly regulated supply of 1,25(OH)2D3."

 

About CIR

 

The founders of Chronic Illness Recovery (CIR), Belinda Fenter and Meg Mangin, are former members of the research team which developed a treatment for chronic inflammation that eventually became known as Inflammation Therapy (IT).

 

Several nurses gained extensive experience counseling patients on this treatment via several websites. In 2008, it became evident there was a pressing need to help more medical practitioners actively participate in the process of nurse-patient counseling during the recovery process. CIR was eventually formed in 2009 to accomplish that goal.

 

CIR believes that helping physicians to become independent practitioners of Inflammation Therapy is a necessary strategy to deliver widespread knowledge, acceptance and availability of this effective treatment.

 

All CIR staff, including Nurse Moderators, are unpaid volunteers. Many people have come together to launch this unique effort to promote a recovery therapy for chronic illness. We're proud and grateful to have their support.

 

 Quotes

 

"What a very real difference you are making in people's lives---I'm grateful for you every single day."  Katherine

 

"Thank you... that is the most thorough/ precise explanation I have ever gotten or understood on this complex issue."  LAcitygirl

 

"I take so much comfort in your direction and look forward to hearing from you."  Marmee